Management Recommendations on Sleep Disturbance of Patients with Parkinson's Disease
Chun-Feng Liu,Tao Wang,Shu-Qin Zhan,De-Qin Geng,Jian Wang,Jun Liu,Hui-Fang Shang,Li-Juan Wang,Piu Chan,Hai-Bo Chen,Sheng-Di Chen,Yu-Ping Wang,Zhong-Xin Zhao,K Ray Chaudhuri
DOI: https://doi.org/10.4103/0366-6999.247210
IF: 6.133
2018-01-01
Chinese Medical Journal
Abstract:iNtroDuCtioN Sleep disturbance is one of the most common nonmotor symptoms in Parkinson’s disease (PD). Sleep disturbance affects 40–98% of PD patients in the world.[1‐3] In China, the prevalence of PD patients with sleep disturbance ranges from 47.66% to 89.10%.[4‐9] Sleep disturbance usually has adverse impact on the quality of life of PD patients. A possible pathogenesis of PD with sleep disturbance include thalamocortical pathway degeneration and changes of neurotransmitter systems.[3] The etiology of sleep disturbance is multifactorial, involving degeneration of areas regulating sleep, sleep structure affected by drugs, sleep disturbance induced by drug, and sleep fragmentation by multiple factors.[3] Although three reviews on the sleep disturbances of PD have recently been published, there is no consensus of recommendations on the management of PD patients with sleep disturbance.[1,3,10]
What problem does this paper attempt to address?